- CH₣2.05bn
- CH₣2.32bn
- €683.83m
Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
Brief: Medacta H1 Adjusted EBITDA EUR 97 Million
Switzerland's Medacta H1 revenue rises 9.7% in constant currency
Brief: Medacta H1 Revenue EUR 368 Million
Europe Research Roundup: Hellofresh, Medacta Group, Neste
Switzerland's Medacta FY revenue rises, profit up on Parcus Medical acquisition
Brief: Medacta FY Adjusted EBITDA EUR 190.8 Million
Switzerland's Medacta FY 2025 revenue growth just short of estimates
Brief: Medacta FY Revenue EUR 683.8 Million Vs. IBES Estimate EUR 687.4 Million
Europe Research Roundup: Aixtron,KBC Groep, Sandvik
Swiss stocks - Factors to watch on October 8
Brief: Medacta H1 Adjusted EBIT EUR 62.4 Million
Brief: Medacta H1 Revenue EUR 344.1 Million
Brief: Medacta FY Adjusted EBIT EUR 94.4 Million
Anika Therapeutics falls after its completes divestiture of Parcus Medical business
Europe Research Roundup: Bellway, Essilorluxottica, LVMH
Swiss stocks - Factors to watch on February 13
Brief: Medacta FY Revenue EUR 590.6 Million Vs. IBES Estimate EUR 581.3 Million
Berenberg predicts 'another eventful year' for MedTech sector